Media Coverage

Back to Resources

05/29/2024 | Media Coverage

Cota, Baptist Health South Florida, And Precisedx Announce Collaboration On The AI-enabled Breast Cancer Recurrence Risk Assessment

05/28/2024 | Media Coverage

PreciseDx Announces Poster Presentation for Breast Cancer Recurrence Test

04/25/2024 | Media Coverage

Novo Nordisk Partnership, Mission Bio Updates Platform, PathAI, Google Cloud Team Up, More

04/25/2024 | Media Coverage

PathAI Enters Partnership With Google Cloud, Cardiometabolic Clinical Trials Platform, DNA/RNA Extraction Kits, More

04/20/2024 | Media Coverage

UCLA And PreciseDx Announce New Collaboration To Advance AI-Enabled Predictions And Risk Mitigation For Triple-Negative Breast Cancer Recurrence

04/09/2024 | Media Coverage

UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence

04/09/2024 | Media Coverage

UCLA partners with PreciseDx to evaluate novel test for breast cancer recurrence

04/08/2024 | Media Coverage

Consultant UCLA, PreciseDx to Develop AI-Powered Breast Cancer Recurrence Tool for Early Detection

04/04/2024 | Media Coverage

UCLA and PreciseDx Collaborate on AI-Powered Breast Cancer Recurrence Diagnostics

04/02/2024 | Media Coverage

UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence

< PREVIOUS 1 2 3 4 5 … 10 NEXT >